Evaluation of Fetuin-A and Antioxidant Levels in Breast Cancer Patients
Main Article Content
The current study was conducted on (90) samples from a sample of women with breast disease. And G2 included 30 samples of breast-infected women who used the treatment. And the control group (the healthy ones) had (30) blood samples. The ages of the groups ranged between (25-74) years, as pictures were collected from the cancerous tumors hospital of a city in Baghdad governorate, between 1/1/2022 to 1/1/2023. after which the serum was obtained, then it was placed in small test tubes and kept in the refrigerator at a temperature of -20 ° C for the purpose of measuring the levels of Fetuin -A, antioxidants and some minerals to know their effect on patients with breast cancer.
The results of the current research showed that there was a significant increase in the blood serum of group G1, with a decrease in the serum of group G2 in the serum of Fetuin -A patients compared with the control group, with a significant decrease in the level of glutathione in the serum of all groups. While the level of malondialdehyde increased significantly (P≤0.05) in the serum of group G1 and G2 compared with healthy subjects, and calcium showed no significant differences in the serum of all groups.